ZURICH (Reuters) - The chairman of Swiss drugmaker Novartis expects Alcon to be valued at between $20 billion and $30 billion when the opthalmic devices unit is spun off to shareholders next year, he said in an interview with Finanz und Wirtschaft.
from Reuters: Business News https://ift.tt/2II3IIS
Saturday, June 30, 2018
Home »
business news
,
latest business news
» Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft
Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft
Train drivers accept pay deal to end strike action
Aslef said 96.6% of its members who voted backed the deal, marking the end of long-running strikes. from BBC News https://ift.tt/LxCn1G9
0 comments:
Post a Comment